annual FCF:
-$398.12M-$783.00K(-0.20%)Summary
- As of today (June 29, 2025), IBRX annual free cash flow is -$398.12 million, with the most recent change of -$783.00 thousand (-0.20%) on December 31, 2024.
- During the last 3 years, IBRX annual FCF has fallen by -$90.14 million (-29.27%).
- IBRX annual FCF is now -154.56% below its all-time high of -$156.40 million, reached on December 31, 2019.
Performance
IBRX Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$87.03M+$229.00K(+0.26%)Summary
- As of today (June 29, 2025), IBRX quarterly free cash flow is -$87.03 million, with the most recent change of +$229.00 thousand (+0.26%) on March 31, 2025.
- Over the past year, IBRX quarterly FCF has increased by +$21.22 million (+19.60%).
- IBRX quarterly FCF is now -176.96% below its all-time high of -$31.42 million, reached on March 31, 2020.
Performance
IBRX quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
-$376.91M+$21.22M(+5.33%)Summary
- As of today (June 29, 2025), IBRX TTM free cash flow is -$376.91 million, with the most recent change of +$21.22 million (+5.33%) on March 31, 2025.
- Over the past year, IBRX TTM FCF has increased by +$35.94 million (+8.71%).
- IBRX TTM FCF is now -1099.50% below its all-time high of -$31.42 million, reached on March 31, 2020.
Performance
IBRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
IBRX Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.2% | +19.6% | +8.7% |
| 3 y3 years | -29.3% | +29.5% | -3.6% |
| 5 y5 years | -154.6% | -177.0% | -1099.5% |
IBRX Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -29.3% | +8.9% | at high | +29.5% | -3.6% | +13.7% |
| 5 y | 5-year | -154.6% | +8.9% | -177.0% | +29.5% | -1099.5% | +13.7% |
| alltime | all time | -154.6% | +8.9% | -177.0% | +29.5% | -1099.5% | +13.7% |
IBRX Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$87.03M(-0.3%) | -$376.91M(-5.3%) |
| Dec 2024 | -$398.12M(+0.2%) | -$87.25M(-14.1%) | -$398.12M(-8.3%) |
| Sep 2024 | - | -$101.56M(+0.5%) | -$434.10M(+2.0%) |
| Jun 2024 | - | -$101.07M(-6.6%) | -$425.62M(+3.1%) |
| Mar 2024 | - | -$108.24M(-12.2%) | -$412.85M(+3.9%) |
| Dec 2023 | -$397.34M(-9.1%) | -$123.23M(+32.4%) | -$397.34M(+3.5%) |
| Sep 2023 | - | -$93.08M(+5.4%) | -$383.77M(-0.9%) |
| Jun 2023 | - | -$88.30M(-4.8%) | -$387.23M(-4.7%) |
| Mar 2023 | - | -$92.74M(-15.4%) | -$406.13M(-7.0%) |
| Dec 2022 | -$436.90M | -$109.66M(+13.6%) | -$436.90M(+6.7%) |
| Sep 2022 | - | -$96.53M(-9.9%) | -$409.28M(+4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$107.20M(-13.2%) | -$393.50M(+8.1%) |
| Mar 2022 | - | -$123.51M(+50.5%) | -$363.94M(+18.2%) |
| Dec 2021 | -$307.98M(+77.6%) | -$82.04M(+1.6%) | -$307.98M(+8.9%) |
| Sep 2021 | - | -$80.75M(+4.0%) | -$282.85M(+17.3%) |
| Jun 2021 | - | -$77.64M(+14.9%) | -$241.13M(+15.1%) |
| Mar 2021 | - | -$67.55M(+18.7%) | -$209.52M(+20.8%) |
| Dec 2020 | -$173.39M(+10.9%) | -$56.91M(+45.8%) | -$173.39M(+48.9%) |
| Sep 2020 | - | -$39.03M(-15.2%) | -$116.49M(+50.4%) |
| Jun 2020 | - | -$46.03M(+46.5%) | -$77.45M(+146.5%) |
| Mar 2020 | - | -$31.42M | -$31.42M |
| Dec 2019 | -$156.40M | - | - |
FAQ
- What is ImmunityBio annual free cash flow?
- What is the all time high annual FCF for ImmunityBio?
- What is ImmunityBio annual FCF year-on-year change?
- What is ImmunityBio quarterly free cash flow?
- What is the all time high quarterly FCF for ImmunityBio?
- What is ImmunityBio quarterly FCF year-on-year change?
- What is ImmunityBio TTM free cash flow?
- What is the all time high TTM FCF for ImmunityBio?
- What is ImmunityBio TTM FCF year-on-year change?
What is ImmunityBio annual free cash flow?
The current annual FCF of IBRX is -$398.12M
What is the all time high annual FCF for ImmunityBio?
ImmunityBio all-time high annual free cash flow is -$156.40M
What is ImmunityBio annual FCF year-on-year change?
Over the past year, IBRX annual free cash flow has changed by -$783.00K (-0.20%)
What is ImmunityBio quarterly free cash flow?
The current quarterly FCF of IBRX is -$87.03M
What is the all time high quarterly FCF for ImmunityBio?
ImmunityBio all-time high quarterly free cash flow is -$31.42M
What is ImmunityBio quarterly FCF year-on-year change?
Over the past year, IBRX quarterly free cash flow has changed by +$21.22M (+19.60%)
What is ImmunityBio TTM free cash flow?
The current TTM FCF of IBRX is -$376.91M
What is the all time high TTM FCF for ImmunityBio?
ImmunityBio all-time high TTM free cash flow is -$31.42M
What is ImmunityBio TTM FCF year-on-year change?
Over the past year, IBRX TTM free cash flow has changed by +$35.94M (+8.71%)